Multiple Assemblies exist for SMTL entry 6ugv
Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a I-centered orthorhombic crystal form, Lot C; X-RAY DIFFRACTION 2.40 Å

SMTL ID
6ugv.1
Ligands
MESO-ERYTHRITOL; 1,2-ETHANEDIOL
Polypeptides
Infliximab Fab Heavy Chain; Infliximab Fab Light Chain
Oligo-state
hetero-1-1-mer
SMTL ID
6ugv.2
Ligands
MESO-ERYTHRITOL; 1,2-ETHANEDIOL
Polypeptides
Infliximab Fab Heavy Chain; Infliximab Fab Light Chain
Oligo-state
hetero-1-1-mer